Sponsor or institution
Clinical trials and research at National Research Center for Hematology, Russia
As of November 12, 2026, Find a Trial lists 4 clinical trials run by National Research Center for Hematology, Russia that are recruiting, in Russia. 1 was first registered in the last 30 days. By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Holding/bridging therapy with a bispecific antibody before CAR-T in aggressive B-cell lymphoma | Phase 2 | Moscow, Moscow | Recruiting | Oct 20, 2026 |
| PET-guided first-line nivolumab plus chemotherapy for advanced Hodgkin lymphoma | Phase 2 | Moscow | Recruiting | Oct 6, 2025 |
| Comparing high and low intensity therapies for relapsed or refractory acute myeloid leukemia | Phase 3 | Moscow | Recruiting | May 17, 2024 |
| Non-intensive treatment for adults with Ph-negative acute lymphoblastic leukemia | — | Moscow | Recruiting | Feb 1, 2024 |
All recruiting trials (4)
-
Holding/bridging therapy with a bispecific antibody before CAR-T in aggressive B-cell lymphoma
This study tests whether a short course of a CD20×CD3 bispecific antibody, given with GemOx or polatuzumab vedotin, helps patients with relapsed or refractory aggressive B-cell lymphoma proceed to planned CD19 CAR-T therapy.
-
PET-guided first-line nivolumab plus chemotherapy for advanced Hodgkin lymphoma
This pilot trial tests whether adding nivolumab to initial chemotherapy and changing treatment based on an early PET scan helps adults with advanced classical Hodgkin lymphoma.
-
Comparing high and low intensity therapies for relapsed or refractory acute myeloid leukemia
This study is testing whether high-intensity or low-intensity therapies work better for adults with relapsed or hard-to-treat acute myeloid leukemia who are getting ready for a stem cell transplant.
-
Non-intensive treatment for adults with Ph-negative acute lymphoblastic leukemia
This study is testing a gentler treatment for adults with Ph-negative acute lymphoblastic leukemia who are in remission but still have some cancer cells, to see if it can help them avoid more intense treatments.
Quick answers
How many clinical trials run by National Research Center for Hematology, Russia are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Russia. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.